JP2009142267A - Method for pulverizing plants that have been unicellularized - Google Patents
Method for pulverizing plants that have been unicellularized Download PDFInfo
- Publication number
- JP2009142267A JP2009142267A JP2008294779A JP2008294779A JP2009142267A JP 2009142267 A JP2009142267 A JP 2009142267A JP 2008294779 A JP2008294779 A JP 2008294779A JP 2008294779 A JP2008294779 A JP 2008294779A JP 2009142267 A JP2009142267 A JP 2009142267A
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- plant
- unicellularized
- powder
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 31
- 238000010298 pulverizing process Methods 0.000 title claims abstract description 22
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 97
- 210000004027 cell Anatomy 0.000 claims abstract description 89
- 239000000843 powder Substances 0.000 claims abstract description 72
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 63
- 239000000725 suspension Substances 0.000 claims abstract description 59
- 210000000170 cell membrane Anatomy 0.000 claims abstract description 47
- 108090000790 Enzymes Proteins 0.000 claims abstract description 21
- 102000004190 Enzymes Human genes 0.000 claims abstract description 21
- 238000004108 freeze drying Methods 0.000 claims abstract description 20
- 238000000227 grinding Methods 0.000 claims abstract description 15
- 238000001694 spray drying Methods 0.000 claims abstract description 11
- 238000005119 centrifugation Methods 0.000 claims abstract description 10
- 239000003381 stabilizer Substances 0.000 claims abstract description 9
- 238000005292 vacuum distillation Methods 0.000 claims abstract description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 26
- 239000000126 substance Substances 0.000 claims description 23
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims description 20
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims description 20
- 229960000984 tocofersolan Drugs 0.000 claims description 16
- 239000002076 α-tocopherol Substances 0.000 claims description 15
- 235000004835 α-tocopherol Nutrition 0.000 claims description 15
- 239000001116 FEMA 4028 Substances 0.000 claims description 14
- 229940087168 alpha tocopherol Drugs 0.000 claims description 14
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 14
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 14
- 229960004853 betadex Drugs 0.000 claims description 14
- 235000011187 glycerol Nutrition 0.000 claims description 13
- 150000005846 sugar alcohols Polymers 0.000 claims description 9
- -1 fatty acid ester Chemical class 0.000 claims description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 235000021466 carotenoid Nutrition 0.000 claims description 3
- 150000001747 carotenoids Chemical class 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 150000001840 cholesterol esters Chemical class 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 239000008157 edible vegetable oil Substances 0.000 claims description 2
- 125000001020 α-tocopherol group Chemical group 0.000 claims 1
- 230000006378 damage Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 239000000693 micelle Substances 0.000 abstract description 4
- 229940097362 cyclodextrins Drugs 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 44
- 230000000052 comparative effect Effects 0.000 description 26
- 238000012360 testing method Methods 0.000 description 24
- 210000002421 cell wall Anatomy 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 19
- 229940088598 enzyme Drugs 0.000 description 19
- 235000010208 anthocyanin Nutrition 0.000 description 14
- 239000004410 anthocyanin Substances 0.000 description 14
- 229930002877 anthocyanin Natural products 0.000 description 14
- 150000004636 anthocyanins Chemical class 0.000 description 14
- 240000004160 Capsicum annuum Species 0.000 description 12
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 12
- 108010059820 Polygalacturonase Proteins 0.000 description 12
- 239000001511 capsicum annuum Substances 0.000 description 12
- 108010093305 exopolygalacturonase Proteins 0.000 description 11
- 210000004051 gastric juice Anatomy 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 210000000936 intestine Anatomy 0.000 description 9
- 239000012530 fluid Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000003834 intracellular effect Effects 0.000 description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 7
- 235000013734 beta-carotene Nutrition 0.000 description 7
- 239000011648 beta-carotene Substances 0.000 description 7
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 7
- 229960002747 betacarotene Drugs 0.000 description 7
- 210000003000 inclusion body Anatomy 0.000 description 7
- 235000019154 vitamin C Nutrition 0.000 description 7
- 239000011718 vitamin C Substances 0.000 description 7
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 6
- 239000001814 pectin Substances 0.000 description 6
- 229920001277 pectin Polymers 0.000 description 6
- 235000010987 pectin Nutrition 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 150000004804 polysaccharides Chemical class 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- 230000002776 aggregation Effects 0.000 description 5
- 238000004220 aggregation Methods 0.000 description 5
- 235000012055 fruits and vegetables Nutrition 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 230000017854 proteolysis Effects 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000012377 drug delivery Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000000851 Vaccinium corymbosum Species 0.000 description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000021014 blueberries Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000006069 physical mixture Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 235000020138 yakult Nutrition 0.000 description 3
- 229920002488 Hemicellulose Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- 241000235527 Rhizopus Species 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000013777 protein digestion Effects 0.000 description 2
- 108010070456 protopectinase Proteins 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108010029182 Pectin lyase Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 244000078912 Trichosanthes cucumerina Species 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical class C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000009754 rhamnogalacturonan I Substances 0.000 description 1
- 239000008914 rhamnogalacturonan II Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Fruits And Vegetables (AREA)
- Storage Of Fruits Or Vegetables (AREA)
Abstract
【課題】 単細胞化植物の濃縮時に生じる細胞同士の再結着を防止すると共に、凍結乾燥時や得られた単細胞化粉末を再懸濁する際の細胞膜の破損も防止する。
【解決手段】 植物に細胞間物質溶解酵素を作用させる第1の工程と、第1の工程により得られた単細胞化された植物を含む懸濁液にシクロデキストリンを添加する第2の工程と、第2の工程により分散された細胞を含む懸濁液を減圧蒸留濃縮もしくは遠心分離にて濃縮する第3の工程と、第3の工程により濃縮された懸濁液を凍結乾燥又は噴霧乾燥にて粉末化する第4の工程とを備えた粉末化方法を用いる。
【効果】 シクロデキストリンが単細胞化された植物の細胞の周囲に集まって表面が親水基のミセルを形成するので、細胞同士の再結着が防止される。また、粉末化後においてもシクロデキストリンが安定化剤として機能するので、細胞膜の状態が保持される。
【選択図】 図3PROBLEM TO BE SOLVED: To prevent reattachment between cells that occurs when a unicellular plant is concentrated, and to prevent damage to a cell membrane during lyophilization or resuspension of the obtained unicellular powder.
A first step of causing an intercellular substance-lytic enzyme to act on a plant, a second step of adding cyclodextrin to a suspension containing a unicellular plant obtained by the first step, A third step of concentrating the suspension containing cells dispersed in the second step by vacuum distillation concentration or centrifugation, and a suspension concentrated in the third step by freeze drying or spray drying A powdering method including a fourth step of powdering is used.
[Effect] Cyclodextrins gather around the cells of a plant that has been unicellularized to form micelles with hydrophilic groups on the surface, thus preventing reattachment between cells. In addition, since the cyclodextrin functions as a stabilizer even after pulverization, the state of the cell membrane is maintained.
[Selection] Figure 3
Description
本発明は、単細胞化処理された植物の粉末化方法に関し、単細胞懸濁液の濃縮化時に生じる細胞の凝集及び密着を防止することが可能で、しかも、濃縮後の凍結乾燥時や得られた単細胞化粉末を再懸濁する際にも、細胞壁と細胞膜の破損を防ぐことができる好適な粉末化方法に関する。 The present invention relates to a method for pulverizing a plant that has been unicellularized, and is capable of preventing cell aggregation and adherence that occurs during the concentration of a single cell suspension, and also obtained during lyophilization after concentration. The present invention also relates to a suitable powdering method capable of preventing the cell wall and the cell membrane from being damaged even when the single cell powder is resuspended.
従来より、いわゆる健康食品や化粧品等の分野において、野菜、果物、薬草などの植物を単細胞化することにより、植物の細胞内に存在する栄養成分、色素成分などの機能性成分を細胞内に閉じ込めたまま粉末化して製品化する技術が利用されている。 Traditionally, in the fields of so-called health foods and cosmetics, plants such as vegetables, fruits and medicinal herbs are made into single cells, thereby trapping functional components such as nutrients and pigments in the cells of the plant. The technology of making powder and commercializing it is used.
単細胞化の利点としては、機能性成分を細胞内に閉じ込めた状態を保持することによる機能性成分の保存性の向上と、加工時に発生する機能性成分の酸化等の変質及びロスの低減が挙げられる。特に、加工時に容易に変質してしまう機能性成分は、ミキサー等を用いて機械的に粉砕・抽出する方法では有効利用できず、細胞壁や細胞膜を破損せずに単細胞化することができて初めてその機能性を十分に利用することができる。 Advantages of unicellularization include improved preservation of functional components by maintaining the state in which functional components are confined in cells, and reduction of alteration and loss such as oxidation of functional components that occur during processing. It is done. In particular, functional components that are easily altered during processing cannot be effectively used in a method of mechanically crushing and extracting using a mixer or the like, and can only be made into single cells without damaging the cell wall or cell membrane. Its functionality can be fully utilized.
植物を単細胞化し粉末化する製法は、大まかには以下の2つの工程からなる。最初の工程は、植物を単細胞化する工程である。植物は多数の細胞が細胞間物質で接着されて構成されているが、この細胞間物質は主にペクチン及びペクチンを不溶化したプロトペクチンを主とする多糖類であり、この多糖類を分解する酵素を作用させることによって植物を単細胞化することができる。 The production method for converting a plant into a single cell and pulverizing generally comprises the following two steps. The first step is a step of making the plant unicellular. Plants are composed of many cells adhered with intercellular substances, which are mainly polysaccharides consisting mainly of pectin and protopectin in which pectin is insolubilized, and enzymes that degrade this polysaccharide. Plants can be made unicellular by acting.
細胞間物質が主としてプロトペクチンからなる場合は、細胞間物質溶解酵素としてペクチナーゼを使用する。ペクチナーゼは、ペクチンを分解する酵素の総称であり、ポリガラクツロナーゼ、ペクチンリアーゼなど、数種類の酵素が混合されたものである。また、Bacillus属、Rhizopus属、Aspergillus 属等、起源となる菌により各酵素の活性及び配分が異なり、それによって特性が変化するので、種々のペクチナーゼが市販されている。 When the intercellular substance is mainly composed of protopectin, pectinase is used as the intercellular substance lytic enzyme. Pectinase is a general term for enzymes that degrade pectin, and is a mixture of several types of enzymes such as polygalacturonase and pectin lyase. In addition, since the activity and distribution of each enzyme varies depending on the origin, such as Bacillus genus, Rhizopus genus, Aspergillus genus, and the characteristics change accordingly, various pectinases are commercially available.
次に、単細胞化された植物の懸濁液を乾燥させて粉末化する工程を実施する。例えば、ペクチナーゼを用いて単細胞化した植物は、単細胞化された細胞を含む懸濁液となる。植物の細胞壁は、セルロースからなる基本骨格が多糖類(マトリックス多糖:ヘミセルロース、ペクチン等)からなる基質に埋め込まれて構成されている。ペクチンは、酸性多糖であり、ホモガラクツロナン、ラムノガラクツロナンI、ラムノガラクツロナンII、アピオガラクツロナン、アラビナン、ガラクタンなどが知られている。 Next, a step of drying and pulverizing the unicellularized plant suspension is performed. For example, a plant unicellularized with pectinase becomes a suspension containing unicellularized cells. The plant cell wall has a basic skeleton made of cellulose embedded in a substrate made of a polysaccharide (matrix polysaccharide: hemicellulose, pectin, etc.). Pectin is an acidic polysaccharide, and homogalacturonan, rhamnogalacturonan I, rhamnogalacturonan II, apiogalacturonan, arabinan, galactan and the like are known.
よって、単細胞化した植物を健康食品や化粧品として製品化するためには、ペクチナーゼによる単細胞化処理を行った後に、単細胞化植物を含んだ懸濁液を乾燥させて粉末化する工程が不可欠である。単細胞化植物の粉末化は噴霧乾燥や凍結乾燥によって実現されている。 Therefore, in order to commercialize unicellularized plants as health foods and cosmetics, it is indispensable to perform a unicellularization treatment with pectinase and then dry and pulverize the suspension containing the unicellularized plants. . The pulverization of a unicellular plant is realized by spray drying or freeze drying.
そこで、上記工程を含む先行技術が幾つか提案されている。
例えば、上記特許文献1には、植物に、Rhizopus属糸状菌から分離される酵素で、強固なプロトペクチンを解離するプロトペクチナーゼを主体とする細胞間物質分解酵素を作用させて、植物柔組織の細胞間物質を分解して植物を単細胞化する方法が開示されている。 For example, in the above-mentioned Patent Document 1, an intercellular substance-degrading enzyme mainly composed of protopectinase that dissociates strong protopectin with an enzyme isolated from a Rhizopus genus filamentous fungus is allowed to act on plants. A method for decomposing an intercellular substance into a single cell of a plant is disclosed.
また、下記特許文献2には、香辛料原料に細胞間物質溶解酵素を作用させて植物組織を崩壊することにより単細胞化または微細組織化するとともに、細胞間物質を溶解除去した香辛料が開示されている。
また、従来より、単細胞化処理された植物の懸濁液を粉末化する方法も種々提案されている。例えば、上記特許文献1には、単細胞懸濁液1ml中の細胞数が105 〜106 程度と少なくなる場合、この液をpH7.0に補正後、スプレードライヤーにかけて噴霧乾燥(スプレードライ)することで単細胞粉末を得る方法が開示されている。 Conventionally, various methods have been proposed for pulverizing plant suspensions that have been unicellularized. For example, in the Patent Document 1, when the number of cells in single cell suspension 1ml decreases as 105 to about 6, after the correction of this solution to pH 7.0, to spray drying subjected spray dryer Thus, a method for obtaining a single cell powder is disclosed.
また、上記特許文献2には、香辛料原料にプロトペクチナーゼなどの酵素を作用させて単細胞化し、篩別した後、得られた懸濁液を遠心分離にかけて上澄みを除去し、得られたペースト状の沈殿物を水洗した後、凍結乾燥(フリーズドライ)して乾燥する方法が開示されている。 In addition, in Patent Document 2, an enzyme such as protopectinase is allowed to act on a spice raw material to be single-celled and sieved, and then the resulting suspension is centrifuged to remove the supernatant, and the obtained paste-like form is obtained. A method is disclosed in which the precipitate is washed with water and then freeze-dried (freeze-dried) to dry it.
しかしながら、特許文献1のように、単細胞化した植物を含んだ懸濁液を噴霧乾燥して粉末化する場合は、例えば120℃以上の熱を加えることになり、細胞膜や細胞内成分に悪影響を与えることは避けられないという問題があった。 However, as in Patent Document 1, when a suspension containing a unicellular plant is spray-dried and powdered, for example, heat of 120 ° C. or higher is applied, which adversely affects cell membranes and intracellular components. There was a problem that giving was inevitable.
また、特許文献2のように、懸濁液を遠心分離にかけて上澄みを除去して濃縮後、凍結乾燥によって粉末化させる方法を用いる場合は、濃縮してペースト状の沈殿物とした時点で細胞間の距離が短くなるため単細胞同士が凝集および密着してしまうという問題があった。 In addition, as in Patent Document 2, when using a method of centrifuging the suspension to remove the supernatant and concentrating and then pulverizing by freeze-drying, the cells are concentrated at the point of concentration to a paste-like precipitate. Since the distance between the single cells becomes short, there is a problem that the single cells aggregate and adhere to each other.
このように、単細胞同士が凝集および密着したままの状態で凍結乾燥を行うと、乾燥後に粉砕して粉末化したときに細胞が破壊されてしまうため、単細胞化の最大の目的である細胞内の機能成分の保護が不可能となる。そこで、懸濁液を濃縮しないか、濃縮の割合を減らすことも考えられたが、1回の凍結乾燥で得られる単細胞化処理された植物の量が少なくなり、コストアップが避けられず採算が取れなくなるので、製品化は困難となる。 In this way, if lyophilization is performed in a state where the single cells are aggregated and in close contact with each other, the cells are destroyed when pulverized and powdered after drying. Protection of functional components becomes impossible. Therefore, it was considered that the suspension was not concentrated or the concentration ratio was reduced, but the amount of the plant that was unicellularized obtained by one freeze-drying was reduced, and the cost increase was unavoidable and profitable. Since it cannot be removed, commercialization becomes difficult.
加えて、従来の製法は、濃縮化時には再接着せず細胞壁が保持されている場合でも、凍結時の氷晶化によって細胞膜が破損するという問題もあった。 In addition, the conventional production method has a problem that the cell membrane is damaged due to ice crystallization during freezing even when the cell wall is not reattached during concentration.
植物細胞はセルロース、へミセルロースなどから構成される細胞壁と、脂質二重膜で構成される細胞膜で細胞内部を保護している。細胞壁は物理的な外力から細胞内を守り、細胞膜は細胞内外の物質の出入りを制御している。したがって、細胞膜が破損した単細胞化粉末は、たとえ細胞壁が破損していない状態であっても、細胞壁の間隙を酸素が自由に通過するため、細胞内の機能性成分は徐々に変質してしまう。同様に、揮発性成分は細胞壁の間隙から細胞外へと放出される。また、細胞膜の破損による最大の問題は、単細胞化粉末を水に懸濁させた時に発生する水溶性成分及び揮発性成分の細胞外への漏洩である。これら成分は懸濁時に速やかに細胞外へ拡散してしまい、単細胞粉末のメリットをすべて損ねてしまう。 Plant cells protect the cell interior with a cell wall composed of cellulose, hemicellulose, etc., and a cell membrane composed of a lipid bilayer. The cell wall protects the cell from physical external forces, and the cell membrane controls the entry and exit of substances inside and outside the cell. Therefore, in the unicellularized powder with the cell membrane damaged, even if the cell wall is not damaged, oxygen freely passes through the gap between the cell walls, so that the functional component in the cell gradually changes in quality. Similarly, volatile components are released out of the cell wall gap. In addition, the biggest problem due to cell membrane breakage is leakage of water-soluble components and volatile components to the outside of the cell, which is generated when unicellularized powder is suspended in water. These components quickly diffuse out of the cell when suspended, and all the merits of the single cell powder are lost.
以上をまとめると、従来の技術には、濃縮化時に生じる細胞の凝集及び密着の問題(以下、第1の課題という。)と、凍結乾燥時や得られた単細胞化粉末を再懸濁する際に生じる細胞膜等の破損の問題(以下、第2の課題という。)があった。 To summarize the above, the conventional techniques include the problem of cell aggregation and adhesion that occurs during concentration (hereinafter referred to as the first problem), and the re-suspension of lyophilized powder or the obtained unicellularized powder. There was a problem of damage to the cell membrane or the like (hereinafter referred to as the second problem).
本発明は、上記した従来の第1及び第2の課題を解決するためになされたものであり、単細胞化された植物を濃縮する際に生じる細胞同士の凝集及び密着を防止することが可能で、しかも、細胞膜の破損を防止することもできる最適な単細胞化粉末を提供することを目的としている。 The present invention has been made to solve the above-described conventional first and second problems, and it is possible to prevent aggregation and adhesion between cells that occur when a unicellular plant is concentrated. And it aims at providing the optimal single cell-ized powder which can also prevent the damage of a cell membrane.
上記の目的を達成するため、本発明の単細胞化処理された植物の粉末化方法は、
植物に細胞間物質溶解酵素を作用させる第1の工程と、
前記第1の工程により得られた単細胞化された植物を含む懸濁液にシクロデキストリンを添加する第2の工程と、
前記第2の工程により分散された細胞を含む懸濁液を減圧蒸留濃縮もしくは遠心分離にて濃縮する第3の工程と、
前記第3の工程により濃縮された懸濁液を凍結乾燥又は噴霧乾燥にて粉末化する第4の工程と、
を備えたことを最も主要な特徴点としている。
In order to achieve the above object, the method for pulverizing a plant subjected to unicellular treatment of the present invention comprises:
A first step of causing an intercellular substance-lytic enzyme to act on a plant;
A second step of adding cyclodextrin to the suspension containing the unicellularized plant obtained by the first step;
A third step of concentrating the suspension containing the cells dispersed in the second step by vacuum distillation concentration or centrifugation;
A fourth step of pulverizing the suspension concentrated in the third step by freeze drying or spray drying;
The most important feature point is to have
また、本発明の植物の単細胞化粉末は、上記粉末化方法により得られる植物の単細胞化粉末であって、細胞膜の安定化剤としてシクロデキストリンを添加したことを最も主要な特徴点としている。 The plant unicellularized powder of the present invention is a plant unicellularized powder obtained by the above-described powdering method, and the most important feature is that cyclodextrin is added as a cell membrane stabilizer.
本発明によれば、シクロデキストリンが単細胞化された植物の細胞の周囲に集まってミセルを形成して表面が親水基となり互いに電気的に反発するので、減圧蒸留濃縮もしくは遠心分離にて濃縮するときでも、単細胞同士の凝集、密着、再結着が防止され、単細胞の状態を保ち細胞壁を破壊することなく粉末化することが可能となり、第1の課題を解決することができる。 According to the present invention, when cyclodextrin is concentrated around a plant cell that has been unicellularized to form micelles and the surfaces become hydrophilic groups and electrically repel each other, when concentrated by vacuum distillation concentration or centrifugation. However, aggregation, adhesion, and reattachment of single cells are prevented, and it becomes possible to maintain the single cell state and powder without destroying the cell wall, thereby solving the first problem.
また、本発明の粉末化方法の第2の工程で添加するシクロデキストリンは、濃縮化後も残存し、細胞膜の安定化剤としても機能するので、懸濁液の凍結乾燥時や得られた単細胞化粉末の再懸濁する際にも、細胞膜の良好な状態が保持され、破損を防止できるので、第2の課題も解決することができる。そのため、本発明の植物の単細胞化粉末は、細胞内部の機能性成分、特に水溶性成分や揮発性成分の変質や漏洩を大幅に低減することができ、さらには、例えば腸に到達するまで機能性成分を細胞内に保持することで、リポソーム製剤と同様のドラッグデリバリーシステムの機能が得られる。 In addition, since the cyclodextrin added in the second step of the powdering method of the present invention remains after concentration and functions as a cell membrane stabilizer, the single cell obtained at the time of lyophilization of the suspension or obtained Even when the powdered powder is resuspended, the good state of the cell membrane is maintained and damage can be prevented, so that the second problem can also be solved. Therefore, the unicellularized powder of the plant of the present invention can greatly reduce the deterioration and leakage of functional components inside the cells, particularly water-soluble components and volatile components, and further function until reaching the intestine, for example. By retaining the sex component in the cell, the function of the drug delivery system similar to that of the liposome preparation can be obtained.
例えば植物に含まれる有益な機能性たんぱく質である各種の酵素や、トランスジェニック植物中に発現させたワクチンタンパク質等は、経口摂取した場合、胃に含まれるたんぱく質分解酵素によって容易に分解される。これらが腸で有効に働く場合、腸に達した時には既に失活しており、酵素やワクチンタンパク質としての機能性を十分に発揮できない。しかし、本発明では、シクロデキストリン又はその誘導体と、必要に応じて多価アルコールや、α−トコフェロール、コレステロール、カロテノイド、食用油脂、脂肪酸、脂肪酸エステル、コレステロールエステルから選択される一又は複数の油性物質を添加することによって細胞膜を安定化しているため、細胞内にある酵素やワクチンは胃での分解を免れ、腸で放出される。そのため、腸内でその酵素やワクチンタンパク質の機能性を十分に発揮することができる。 For example, various enzymes, which are useful functional proteins contained in plants, vaccine proteins expressed in transgenic plants, and the like are easily degraded by proteolytic enzymes contained in the stomach when ingested. When these work effectively in the intestines, they are already deactivated when they reach the intestines and cannot fully function as enzymes or vaccine proteins. However, in the present invention, cyclodextrin or a derivative thereof and, if necessary, one or more oily substances selected from polyhydric alcohol, α-tocopherol, cholesterol, carotenoid, edible oil, fatty acid, fatty acid ester, cholesterol ester Since the cell membrane is stabilized by adding, the enzymes and vaccines inside the cells are released from the stomach and released from the intestines. Therefore, the functionality of the enzyme or vaccine protein can be sufficiently exerted in the intestine.
本発明は、第1及び第2の課題を解決するという目的を、植物に細胞間物質溶解酵素を作用させる第1の工程と、前記第1の工程により得られた単細胞化された植物を含む懸濁液にシクロデキストリンを添加する第2の工程と、前記第2の工程により分散された細胞を含む懸濁液を減圧蒸留濃縮もしくは遠心分離にて濃縮する第3の工程と、前記第3の工程により濃縮された懸濁液を凍結乾燥又は噴霧乾燥にて粉末化する第4の工程とを備えた粉末化方法を採用することによって達成した。以下、本発明の第1〜第4の工程の一例を具体的に説明する。 The object of the present invention is to solve the first and second problems by including a first step of causing an intercellular substance lytic enzyme to act on a plant, and a unicellular plant obtained by the first step. A second step of adding cyclodextrin to the suspension; a third step of concentrating the suspension containing cells dispersed in the second step by vacuum distillation concentration or centrifugation; and the third step. And a fourth step of pulverizing the suspension concentrated by the step of freeze-drying or spray-drying. Hereinafter, an example of the 1st-4th process of this invention is demonstrated concretely.
(第1の工程)
第1の工程は、植物に細胞間物質溶解酵素を作用させる工程である。細胞間物質溶解酵素としては、例えばペクチナーゼを使用することができる。例えば、植物を所要のサイズに切断した後、水に浸し、ペクチナーゼが所定の重量%となるように調整した酵素液を添加し、酵素反応させると、単細胞を含む懸濁液の状態となる。なお、細胞壁分解酵素を併用して同時に細胞壁を分解し、プロトプラストとしてもよい。細胞壁分解酵素としては、例えばセルラーゼを使用することができる。第1の工程により、植物は単細胞化された懸濁液の状態となる。
(First step)
The first step is a step of causing an intercellular substance lytic enzyme to act on the plant. As the intercellular substance lytic enzyme, for example, pectinase can be used. For example, when a plant is cut to a required size and then immersed in water, an enzyme solution prepared so that pectinase is at a predetermined weight% is added and subjected to an enzyme reaction, a suspension containing single cells is obtained. In addition, it is good also as a protoplast by decomposing | disassembling a cell wall simultaneously using a cell wall decomposing enzyme together. For example, cellulase can be used as the cell wall degrading enzyme. By the first step, the plant becomes a single cell suspension.
この懸濁液には残渣が含まれているため、20メッシュ(JIS)の篩で濾過し、残渣を取り除く。こうして得られた懸濁液は、時間が経過すると単細胞粒子が沈殿し、2層に分離する。 Since this suspension contains residue, it is filtered through a 20 mesh (JIS) sieve to remove the residue. In the suspension thus obtained, single cell particles are precipitated over time and separated into two layers.
(第2の工程)
第2の工程は、第1の工程により得られた単細胞化された植物を含む懸濁液にシクロデキストリンを添加する工程である。具体的には、例えば第1の工程で得られた懸濁液100重両部に対し、シクロデキストリン0.1〜5重量部を微量添加してよく攪拌する。シクロデキストリンはグルコースが5個以上結合した環状オリゴ糖の一種である。
(Second step)
The second step is a step of adding cyclodextrin to the suspension containing the unicellularized plant obtained by the first step. Specifically, for example, a small amount of 0.1 to 5 parts by weight of cyclodextrin is added to 100 parts by weight of the suspension obtained in the first step and stirred well. Cyclodextrin is a kind of cyclic oligosaccharide in which 5 or more glucoses are bonded.
また、第2工程で、シクロデキストリンと共に多価アルコールを添加しても良い。多価アルコールも、シクロデキストリンと共に、単細胞化粉末の細胞膜の安定化剤として機能するからである。具体的には、植物100重量部に対し、シクロデキストリン0.05〜10重量部と多価アルコール0.005〜5重量部を添加して充分に時間をかけて緩やかに攪拌する。なお、懸濁液には残渣が含まれるため、必要に応じてフィルターでろ過を行う。 Moreover, you may add a polyhydric alcohol with a cyclodextrin at a 2nd process. This is because the polyhydric alcohol also functions as a stabilizer for the cell membrane of the unicellular powder together with the cyclodextrin. Specifically, with respect to 100 parts by weight of a plant, 0.05 to 10 parts by weight of cyclodextrin and 0.005 to 5 parts by weight of a polyhydric alcohol are added and gently stirred over a sufficient time. In addition, since a residue is contained in suspension, it filters with a filter as needed.
添加する多価アルコールとしては、グリセリン、エチレングリコール、プロピレングリコール、ポリエチレングリコール、ジエチレングリコールなどから選択できる。より好ましくはグリセリンを使用する。 The polyhydric alcohol to be added can be selected from glycerin, ethylene glycol, propylene glycol, polyethylene glycol, diethylene glycol and the like. More preferably glycerin is used.
なお、第2工程は第1工程と同時に実施することも可能である。すなわち、同じ反応槽に細胞間物質溶解酵素とシクロデキストリンを同時に添加して作用させてもよく、また反応槽に添加する順序はシクロデキストリンの方が先になっても構わない。 The second step can be performed simultaneously with the first step. That is, the intercellular substance-dissolving enzyme and cyclodextrin may be added to the same reaction tank at the same time, and the order of addition to the reaction tank may be preceded by cyclodextrin.
添加するシクロデキストリンとしては、α−シクロデキストリン、β−シクロデキストリン、γ−シクロデキストリン、それらの誘導体のどれを用いても良い。本発明において「シクロデキストリン」は、その誘導体を含むものである。また、非分岐シクロデキストリン、分岐シクロデキストリン(グルコシルシクロデキストリン、マルトシルシクロデキストリンなど)、シクロデキストリン誘導体(ジメチルシクロデキストリン、ヒドロキシエチルシクロデキストリンなど)のどれを用いても良い。 As the cyclodextrin to be added, any of α-cyclodextrin, β-cyclodextrin, γ-cyclodextrin, and derivatives thereof may be used. In the present invention, “cyclodextrin” includes derivatives thereof. Any of unbranched cyclodextrin, branched cyclodextrin (glucosyl cyclodextrin, maltosyl cyclodextrin, etc.) and cyclodextrin derivatives (dimethyl cyclodextrin, hydroxyethyl cyclodextrin, etc.) may be used.
もっとも、本発明者等が種々検討したところによると、γ体のシクロデキストリンは、水への溶解性が高いので、より好ましいことが判明している。また、細胞同士の再結着を防ぐ第1の課題に対しては、マルトシルβシクロデキストリンがより好ましいことが判明している。 However, according to various studies by the present inventors, it has been found that γ-form cyclodextrin is more preferable because of its high solubility in water. It has also been found that maltosyl β cyclodextrin is more preferable for the first problem of preventing reattachment between cells.
非分岐シクロデキストリン、分岐シクロデキストリン、シクロデキストリン誘導体の内部は、疎水性(親油性)、外部は親水性となっている。シクロデキストリンによって各細胞粒子は表面が親水基のミセルを形成するので、このミセル化した各細胞粒子は電気的な反発により分散し、各単細胞が分散した好適な懸濁液を得ることができる。 The inside of the unbranched cyclodextrin, the branched cyclodextrin, and the cyclodextrin derivative is hydrophobic (lipophilic) and the outside is hydrophilic. Since each cell particle forms a micelle having a hydrophilic group on the surface by cyclodextrin, each of the micellized cell particles is dispersed by electrical repulsion, and a suitable suspension in which each single cell is dispersed can be obtained.
また、第2工程で、α−トコフェロール、コレステロール、カロテノイド、食用油脂、脂肪酸、脂肪酸エステル、コレステロールエステルから選択される一又は複数の油性物質を、シクロデキストリン、多価アルコールと共に併用してもよい。前記油性成分も、シクロデキストリン、多価アルコールと共に、単細胞化粉末の細胞膜の安定化剤として機能するからである。ここで、前記油性物質はシクロデキストリン包接体であってもよいし、シクロデキストリンとの物理的混合物でも、前記包接体及び物理的混合物の混在した状態でもよい。具体的には、シクロデキストリン100重量部に対して前記油性物質10〜50重量部を添加して充分に時間をかけて緩やかに攪拌する。前記包接体として使用する場合は、シクロデキストリンと前記油性物質とを強攪拌等の一般的な方法で先に包接体としたものを、単細胞化された植物の懸濁液に添加して充分に時間をかけて緩やかに攪拌する。なお、モル比でα−トコフェロール:γ−シクロデキストリン=1:2となるように調整したα−トコフェロールγ−シクロデキストリン包接体を使用することで細胞膜の安定性が最も高くなることが判明している。これは、前記油性物質単体やシクロデキストリン単体よりも、前記油性物質のシクロデキストリン包接体のほうが、細胞膜との結合性が高い為だと考えられる。 In the second step, one or more oily substances selected from α-tocopherol, cholesterol, carotenoids, edible fats and oils, fatty acids, fatty acid esters, and cholesterol esters may be used in combination with cyclodextrin and polyhydric alcohol. This is because the oil component also functions as a cell membrane stabilizer of the unicellular powder together with cyclodextrin and polyhydric alcohol. Here, the oily substance may be a cyclodextrin inclusion body, a physical mixture with cyclodextrin, or a state in which the inclusion body and the physical mixture are mixed. Specifically, 10 to 50 parts by weight of the oily substance is added to 100 parts by weight of cyclodextrin and gently stirred over a sufficient time. In the case of using as an inclusion body, cyclodextrin and the oily substance are first added to the inclusion body by a general method such as strong stirring, and then added to the unicellularized plant suspension. Stir gently over time. It was found that the stability of the cell membrane was maximized by using an α-tocopherol γ-cyclodextrin inclusion body adjusted so that the molar ratio was α-tocopherol: γ-cyclodextrin = 1: 2. ing. This is thought to be because the cyclodextrin inclusion body of the oily substance has higher binding properties with the cell membrane than the oily substance alone or the cyclodextrin simple substance.
(第3の工程)
第3の工程は、第2の工程で得られた単細胞が分散された懸濁液を、遠心分離または減圧蒸留濃縮により濃縮する工程である。遠心分離を用いる場合は、例えば、懸濁液を1500Gで10分間遠心分離機にかけてミセル化した単細胞粒子を分離した後、水を加えて濃縮率を整えた懸濁液を得る。また、減圧蒸留濃縮を用いる場合は、例えば、減圧蒸留濃縮装置を用いて懸濁液を減圧下で30℃に保ち蒸留濃縮し、濃縮された懸濁液を得る。本発明では、第2工程において、シクロデキストリンを添加していることにより、細胞同士の接着が防止されるため、従来の技術では再接着を起こして後の粉末化の工程で細胞壁破壊の原因となっていた高濃縮化が可能となる。
(Third step)
The third step is a step of concentrating the suspension in which the single cells obtained in the second step are dispersed by centrifugation or vacuum distillation concentration. In the case of using centrifugation, for example, the suspension is centrifuged at 1500 G for 10 minutes to separate the micellar single cell particles, and then water is added to obtain a suspension in which the concentration rate is adjusted. When using vacuum distillation concentration, for example, the suspension is distilled and concentrated at 30 ° C. under reduced pressure using a vacuum distillation concentrator to obtain a concentrated suspension. In the present invention, the addition of cyclodextrin in the second step prevents cell-to-cell adhesion. Therefore, the conventional technique causes re-adhesion and causes cell wall destruction in the subsequent powdering step. The high concentration that has been achieved becomes possible.
(第4の工程)
第4の工程は、第3の工程により濃縮された懸濁液を凍結乾燥(フリーズドライ)又は噴霧乾燥(スプレードライ)にて粉末化する工程である。凍結乾燥を用いる場合、粉末化は、例えば、濃縮された懸濁液を−30℃で予備冷凍後、真空凍結乾燥器にて最終品温が60℃以下となるよう50時間程度乾燥させ、その後、適度な圧力を加えて打撃することで粉砕することにより実施される。以上の第1〜第4の工程により、単細胞化された状態をそのまま保って健康食品や化粧品用の粉末を得ることができる。
(Fourth process)
The fourth step is a step of pulverizing the suspension concentrated in the third step by freeze drying (freeze drying) or spray drying (spray drying). When lyophilization is used, powdering is performed by, for example, pre-freezing the concentrated suspension at −30 ° C., and then drying in a vacuum freeze dryer for about 50 hours so that the final product temperature is 60 ° C. or lower. It is carried out by crushing by applying an appropriate pressure and hitting. By the above first to fourth steps, it is possible to obtain a powder for health foods and cosmetics while maintaining the unicellular state as it is.
以下、本発明の効果を確認するために実施した試験1〜5を示し、本発明をさらに具体的に説明する。但し、本発明は、以下の実施例に限定されるものではない。 Hereinafter, tests 1 to 5 performed for confirming the effects of the present invention will be shown, and the present invention will be described more specifically. However, the present invention is not limited to the following examples.
〔試験1:単細胞懸濁液を高濃縮した際の再結着防止効果の確認〕
人参にペクチナーゼ(マセロチームA(登録商標):ヤクルト薬品工業社製)を作用させて単細胞化し、減圧蒸留濃縮にて濃縮する際の条件を変化させて、凍結乾燥によって得られた粉末の性質を比較した。なお、得られた粉末中の細胞からの内容成分の流出量を確認するため、細胞内に色素(βカロテン)が多く含まれる人参を使用した。
[Test 1: Confirmation of anti-reattachment effect when single cell suspension is highly concentrated]
Compare the properties of powder obtained by freeze-drying by changing pectinase (MaceroTeam A (registered trademark): Yakult Yakuhin Kogyo Co., Ltd.) into single cells and changing the concentration conditions by vacuum concentration. did. In addition, in order to confirm the outflow amount of the content component from the cells in the obtained powder, carrots containing a large amount of pigment (β-carotene) were used.
(酵素処理)
人参100gを5mm角に切断した後、300gの蒸留水に浸し、上記ペクチナーゼの割合が水と人参を併せた総重量に対して0.5重量%となるように調整した酵素液を添加して45℃、120分間攪拌下(300rpm)で反応させて懸濁液を得た。残渣を20メッシュ(JIS)の篩で濾過して単細胞を含む懸濁液を得た。
(Enzyme treatment)
After cutting 100 g of carrots into 5 mm squares, immerse them in 300 g of distilled water and add an enzyme solution adjusted so that the ratio of the pectinase is 0.5% by weight based on the total weight of water and carrots. The suspension was reacted at 45 ° C. for 120 minutes with stirring (300 rpm). The residue was filtered through a 20 mesh (JIS) sieve to obtain a suspension containing single cells.
(濃縮)
単細胞を含む懸濁液へのシクロデキストリンの添加については、以下のように条件を変えて、比較例1、実施例1〜3とした。
比較例1: シクロデキストリンを添加しないもの
実施例1: 懸濁液に対しβ−シクロデキストリン(CAVAMAX (登録商標)W7、Wacker-Chemie GmbH社)1重量%を添加するもの
実施例2: 懸濁液に対しγ−シクロデキストリン(CAVAMAX (登録商標)W8、Wacker-Chemie GmbH社)1重量%を添加するもの
実施例3: 懸濁液に対しマルトシルβシクロデキストリン(G2−β−CDTM、横浜国際バイオ研究所製)1重量%を添加するもの
(concentrated)
About addition of the cyclodextrin to the suspension containing a single cell, it changed into conditions as follows and set it as the comparative example 1 and Examples 1-3.
Comparative Example 1: No cyclodextrin added Example 1: β-cyclodextrin (CAVAMAX (registered trademark) W7, Wacker-Chemie GmbH) 1 wt% added to the suspension Example 2: Suspension Addition of 1% by weight of γ-cyclodextrin (CAVAMAX (registered trademark) W8, Wacker-Chemie GmbH) to the liquid Example 3: Maltosyl β cyclodextrin (G2-β-CDTM, Yokohama International) to the suspension Bio-laboratory) 1% by weight added
各懸濁液は、スターラーを用いてよく攪拌し、1時間静置した。これら4つの条件で、懸濁液の重量のそれぞれ2.5〜5倍まで減圧蒸留濃縮にて濃縮した。 Each suspension was stirred well using a stirrer and allowed to stand for 1 hour. Under these four conditions, each was concentrated by distillation under reduced pressure to 2.5 to 5 times the weight of the suspension.
(凍結乾燥)
濃縮した懸濁液を冷蔵庫にて24時間静置した後、冷凍庫にて凍結した。この凍結した懸濁液を凍結乾燥により乾燥させて粉末を得た。得られた乾燥粉末を0.01g取り、10ccの水に再度添加し、MICROTUBE MIXER MT360(TOMY社製) を用いて15分攪拌させたのち、顕微鏡を用いて細胞の状態を確認した。なお、比較例1、実施例1〜3について、それぞれ2回ずつ試験を行った。結果は、表1に示すとおりとなった。
(freeze drying)
The concentrated suspension was allowed to stand for 24 hours in a refrigerator and then frozen in a freezer. This frozen suspension was dried by lyophilization to obtain a powder. 0.01 g of the obtained dry powder was taken, added again to 10 cc of water, stirred for 15 minutes using MICROTUBE MIXER MT360 (manufactured by TOMY), and the state of the cells was confirmed using a microscope. In addition, about the comparative example 1 and Examples 1-3, the test was done twice, respectively. The results are as shown in Table 1.
単細胞化した植物の懸濁液を濃縮する場合、比較例1のようにシクロデキストリンを添加せずにそのまま濃縮すると、図5(a)に示すように、細胞同士が密着した状態(いくつもの細胞が重なりあった状態)が見られた。また、細胞同士が密着した状態のため、凍結乾燥時もしくは乾燥後粉砕時に細胞壁の破損の原因となり、図5(b)に示すように、内容成分が流出して塊状になったものが多く見られた。この結果は、内容成分が揮発性であれば粉砕時に失われてしまうことを示している。なお、図1は、比較例1の顕微鏡写真全体を表したものである。 When concentrating a unicellular plant suspension, as shown in FIG. 5 (a), when cells are concentrated without adding cyclodextrin as in Comparative Example 1, the cells are in close contact with each other (several cells). Was observed). In addition, since the cells are in close contact with each other, it may cause damage to the cell wall during freeze-drying or pulverization after drying. As shown in FIG. It was. This result indicates that if the content component is volatile, it is lost during grinding. FIG. 1 shows the entire photomicrograph of Comparative Example 1.
一方、実施例1〜3のように、シクロデキストリンを微量添加した懸濁液を濃縮した本発明の場合は、細胞同士の密着がほとんどないという結果が得られた。具体的には、図2は、β−シクロデキストリンを添加した実施例1の顕微鏡写真を、図3は、マルトシルβシクロデキストリンを添加した実施例2の顕微鏡写真を、図4は、γ−シクロデキストリンを添加した実施例3の顕微鏡写真を示している。何れも細胞同士の密着がなく、細胞の内容成分の流出が低減されている。 On the other hand, as in Examples 1 to 3, in the case of the present invention in which the suspension to which a small amount of cyclodextrin was added was concentrated, the result that there was almost no adhesion between cells was obtained. Specifically, FIG. 2 is a micrograph of Example 1 to which β-cyclodextrin was added, FIG. 3 is a micrograph of Example 2 to which maltosyl β-cyclodextrin was added, and FIG. Fig. 3 shows a photomicrograph of Example 3 with the addition of dextrin. None of the cells are in close contact with each other, and the outflow of cell content components is reduced.
特に、マルトシルβシクロデキストリンでは、濃縮した懸濁液の重量(g)に対する得られた乾燥粉末の重量(g)の割合が10%以上の高濃縮時でも、図3に示すように、細胞同士の密着がないだけでなく、細胞が均一に分散しており、好適な結果が得られた。 In particular, in the case of maltosyl β cyclodextrin, the ratio of the weight (g) of the obtained dry powder to the weight (g) of the concentrated suspension is high even when the concentration is 10% or more. In addition to the lack of adhesion, the cells were uniformly dispersed, and favorable results were obtained.
懸濁液にシクロデキストリンを添加すると、懸濁液中の細胞の細胞壁に存在するペクチンのカルボキシル基、メチルエステル化したカルボキシル基などをシクロデキストリンが包接すると考えられる。シクロデキストリンの外部はヒドロキシ基が多数存在し、親水性を示すため、液中で細胞同士が反発し、高濃度に濃縮した場合でも細胞間の距離が保たれる。 When cyclodextrin is added to the suspension, it is considered that the cyclodextrin includes carboxy groups of pectin and methyl esterified carboxyl groups present on the cell walls of the cells in the suspension. Since many hydroxy groups exist outside the cyclodextrin and show hydrophilicity, the cells repel each other in the liquid, and even when concentrated to a high concentration, the distance between the cells is maintained.
シクロデキストリンの水への溶解度は、25℃で、α体が14.5g/100mL、β体が1.8g/100mL、γ体が23.2g/100mL、マルトシルβシクロデキストリンが162g/100mLであり、β体はその溶解性が一番低い。上記実験では、β体よりもγ体、γ体よりもマルトシルβシクロデキストリンの方が良い結果が得られており、本発明で得られる作用には、シクロデキストリンの水への溶解性が関連していると考えられる。特に、マルトシルβシクロデキストリンを用いた場合、最も良い結果が得られることがわかった。 The solubility of cyclodextrin in water is 14.5 g / 100 mL for α form, 1.8 g / 100 mL for β form, 23.2 g / 100 mL for γ form, and 162 g / 100 mL for maltosyl β cyclodextrin at 25 ° C. Β-form has the lowest solubility. In the above experiment, the γ form was better than the β form, and maltosyl β cyclodextrin was better than the γ form. The action obtained in the present invention is related to the solubility of cyclodextrin in water. It is thought that. In particular, it was found that the best results were obtained when maltosyl β cyclodextrin was used.
もっとも、γ−シクロデキストリンは、マルトシルβシクロデキストリンよりも低コストで実施できるため、コストをなるべく抑えつつ一定レベル以上の良い効果を得たい場合は、γ−シクロデキストリンを用いるのが望ましい。 However, since γ-cyclodextrin can be carried out at a lower cost than maltosyl β cyclodextrin, it is desirable to use γ-cyclodextrin when it is desired to obtain a good effect of a certain level or more while suppressing the cost as much as possible.
〔試験2−1:単細胞化粉末の細胞膜保持率の測定)
(単細胞化粉末の作成)
ペクチナーゼ(マセロチームA(登録商標):ヤクルト薬品工業社製):5%を添加した酵素反応液20mlに、一辺5mmに刻んだオーストラリア産ブルーベリーの果皮10gを加え、37℃で5時間インキュベートして単細胞懸濁液を作成し、20メッシュのフィルターを用いて残渣を取り除いた。この懸濁液1ml(アントシアニン含有赤色細胞の数:3.5×103 /ml)に対し、γ−シクロデキストリン(CAVAMAX (登録商標)W8、Wacker-Chemie GmbH社)、グリセリン(和光純薬工業社製 特級)、α−トコフェロール(dl−α−トコフェロール、和光純薬工業社製)の量を下記実施例A〜Dのように変化させて添加し、充分に時間をかけて均一になるように緩やかに攪拌した後に遠心分離(1500G×10分)によって上清を取り除き、残った沈殿を凍結乾燥して単細胞化粉末を得た。また、シクロデキストリン、グリセリン、α−トコフェロールを全く添加せず、その他は全く同じ方法で単細胞化粉末を作成し比較例aとした。さらに、シクロデキストリン、グリセリン、α―トコフェロールを全く添加せず、デキストリン(アミコールR:日澱化学社製)を添加し、その他は全く同じ方法で単細胞化粉末を作成し比較例bとした。
[Test 2-1: Measurement of cell membrane retention of unicellularized powder]
(Making unicellular powder)
Pectinase (Macero Team A (registered trademark): Yakult Yakuhin Kogyo Co., Ltd.): To 20 ml of enzyme reaction solution with 5% added, 10 g of Australian blueberry peel cut into 5 mm sides was added, and incubated at 37 ° C. for 5 hours to give a single cell A suspension was made and the residue was removed using a 20 mesh filter. Γ-cyclodextrin (CAVAMAX (registered trademark) W8, Wacker-Chemie GmbH), glycerin (Wako Pure Chemical Industries, Ltd.) per 1 ml of this suspension (the number of red cells containing anthocyanin: 3.5 × 10 3 / ml) Special grade), α-tocopherol (dl-α-tocopherol, manufactured by Wako Pure Chemical Industries, Ltd.) is added in an amount changed as in Examples A to D below so that it becomes uniform over time. After gently stirring, the supernatant was removed by centrifugation (1500 G × 10 minutes), and the remaining precipitate was lyophilized to obtain a unicellularized powder. In addition, cyclodextrin, glycerin, and α-tocopherol were not added at all, and a unicellular powder was prepared in exactly the same manner as Comparative Example a. Further, cyclodextrin, glycerin and α-tocopherol were not added at all, dextrin (Amicol R: manufactured by Nissho Chemical Co., Ltd.) was added, and other unicellular powders were prepared in exactly the same manner as Comparative Example b.
(懸濁液1mlに対する添加量)
実施例A γ−シクロデキストリン 1.0%
実施例B γ−シクロデキストリン 1.0%
グリセリン 0.1%
実施例C γ−シクロデキストリン 1.0%
グリセリン 0.1%
α−トコフェロール 0.2%
実施例D α−トコフェロールγ−シクロデキストリン
包接体(α−トコフェロール:シクロデキス
トリンの重量比=1:5) 1.0%
グリセリン 0.1%
比較例a 添加せず
比較例b デキストリン 1.0%
(Amount added to 1 ml of suspension)
Example A γ-cyclodextrin 1.0%
Example B γ-cyclodextrin 1.0%
Glycerin 0.1%
Example C γ-cyclodextrin 1.0%
Glycerin 0.1%
α-Tocopherol 0.2%
Example D α-Tocopherol γ-Cyclodextrin
Inclusion body (α-tocopherol: cyclodex
Thrin weight ratio = 1: 5) 1.0%
Glycerin 0.1%
Comparative Example a No addition Comparative Example b Dextrin 1.0%
(細胞膜の保持率)
上記のようにして得られた各粉末をそれぞれ蒸留水1mlに懸濁し、アントシアニン含有赤色細胞のうち、細胞膜が破損していない細胞の数を顕微鏡下でカウントした。なお、細胞膜が破損していないアントシアニン含有赤色細胞の例として、実施例Dの粉末を水に再懸濁時の細胞を図7に示す。結果は以下の表2のようになった。
(Cell membrane retention)
Each powder obtained as described above was suspended in 1 ml of distilled water, and among the anthocyanin-containing red cells, the number of cells whose cell membrane was not damaged was counted under a microscope. As an example of the anthocyanin-containing red cells in which the cell membrane is not damaged, the cells when the powder of Example D is resuspended in water are shown in FIG. The results are shown in Table 2 below.
表2により明らかなように、何も添加せずに粉末化した比較例aやデキストリンを添加して粉末化した比較例bの場合、粉末の再懸濁時に細胞膜を保持した細胞が全体の10%未満と微量であるのに対して、実施例Aでは、γ−シクロデキストリンを微量添加することにより、細胞膜を保持した赤色細胞が全体の50%以上と有意に増加し、細胞膜が安定化したことが確認された。さらに、実施例B、C、Dでは、グリセリン、α−トコフェロールをシクロデキストリンと併せて微量加えることによって、細胞膜を保持した赤色細胞が全体の70%〜90%となり、細胞膜の安定性がさらに増加することが確認された。さらに実施例C、Dの比較により、α−トコフェロールとγシクロデキストリンの物理的混合物よりも、α−トコフェロールγシクロデキストリン包接体の方が細胞膜の安定性を高めることが確認された。 As is clear from Table 2, in the case of Comparative Example a powdered without adding anything and Comparative Example b powdered with dextrin, 10% of the cells retaining the cell membrane were resuspended when the powder was resuspended. In Example A, the amount of red cells retaining the cell membrane was significantly increased to 50% or more of the whole, and the cell membrane was stabilized in Example A by adding a small amount of γ-cyclodextrin. It was confirmed. Furthermore, in Examples B, C and D, by adding a small amount of glycerin and α-tocopherol together with cyclodextrin, the red cells holding the cell membrane become 70% to 90% of the total, and the stability of the cell membrane is further increased. Confirmed to do. Furthermore, by comparing Examples C and D, it was confirmed that the inclusion stability of α-tocopherol γ cyclodextrin was higher than that of a physical mixture of α-tocopherol and γ cyclodextrin.
〔試験2−2:細胞膜保持率の測定〕
(単細胞化粉末の作成)
北欧産青果ブルーベリー10gを、細胞間物質溶解酵素(ペクトリアーゼY−23、盛進工業社製):0.5%)、γ−シクロデキストリン(CAVAMAX (登録商標)W8、Wacker-Chemie GmbH社):0.5%、グリセリン(和光純薬工業社製 特級):0.1%を含む30mlの溶液に浸漬し、40℃で1時間インキュベートして単細胞化した。上記反応液から20メッシュ(JIS)のフィルターにて残渣を取り除いた後、遠心分離(1500G×10分)によって濃縮した後、凍結乾燥して本発明にかかるブルーベリー単細胞化粉末0.2gを得た(以下、実施例4とする)。比較対照には、γ−シクロデキストリン及びグリセリンを添加しない以外は上記と全く同じ方法で得られる単細胞化粉末を使用した(以下、比較例2とする。)。
[Test 2-2: Measurement of cell membrane retention]
(Making unicellular powder)
Scandinavian fruit and vegetable blueberry (10 g), intercellular substance lytic enzyme (Pectriase Y-23, manufactured by Shengshin Kogyo Co., Ltd .: 0.5%), γ-cyclodextrin (CAVAMAX (registered trademark) W8, Wacker-Chemie GmbH): 0.5% glycerin (special grade, manufactured by Wako Pure Chemical Industries, Ltd.): It was immersed in 30 ml of a solution containing 0.1%, and incubated at 40 ° C. for 1 hour to obtain single cells. After removing the residue from the reaction solution with a 20 mesh (JIS) filter, the residue was concentrated by centrifugation (1500 G × 10 minutes) and then freeze-dried to obtain 0.2 g of blueberry unicellularized powder according to the present invention. (Hereinafter referred to as Example 4). As a comparative control, a unicellularized powder obtained by the same method as above except that γ-cyclodextrin and glycerin were not added was used (hereinafter referred to as Comparative Example 2).
(細胞内アントシアニン保持率の調査)
細胞膜が破損していると、単細胞化粉末を蒸留水に懸濁させた時に容易にアントシアニン等の水溶性成分が流出する。そこで、実施例4と比較例2で、細胞内アントシアニン保持率=((総アントシアニン量)−(漏洩したアントシアニン量))/(単細胞化粉末の総アントシアニン量)を夫々調査した。
(Investigation of intracellular anthocyanin retention rate)
If the cell membrane is damaged, water-soluble components such as anthocyanins easily flow out when the unicellularized powder is suspended in distilled water. Therefore, in Example 4 and Comparative Example 2, the intracellular anthocyanin retention rate = ((total anthocyanin amount) − (leaked anthocyanin amount)) / (total anthocyanin amount of unicellular powder) was investigated.
なお、漏洩したアントシアニン量は、単細胞化粉末0.05gを蒸留水1mlに懸濁させて4℃にて1晩静置したのち、遠心分離(1500G)によって分離した上清のアントシアニン量から算出した。また、アントシアニン量は1%塩酸酸性メタノールにて100℃×1時間加熱して抽出されるデルフィニジンの極大吸収波長の吸光度から算出した。試験結果は、表3に示すとおりとなった。 The amount of leaked anthocyanins was calculated from the amount of anthocyanins in the supernatant separated by centrifugation (1500 G) after suspending 0.05 g of unicellularized powder in 1 ml of distilled water and allowing to stand at 4 ° C. overnight. . The amount of anthocyanin was calculated from the absorbance at the maximum absorption wavelength of delphinidin extracted by heating at 100 ° C. for 1 hour with 1% hydrochloric acid acidic methanol. The test results are as shown in Table 3.
表3により明らかなように、本発明にかかる実施例4の単細胞化粉末は、γ−シクロデキストリン及びグリセリンの添加により細胞膜が安定化しているため、比較例2の単細胞化粉末と比較すると、水溶性成分の細胞外への漏洩がはるかに低減されており、かつ、粉末としてのアントシアニン含有量も10%向上していることが確認された。 As is clear from Table 3, the single-cellized powder of Example 4 according to the present invention has a cell membrane that is stabilized by the addition of γ-cyclodextrin and glycerin. It was confirmed that the leakage of the sex component to the outside of the cell was much reduced and the anthocyanin content as a powder was also improved by 10%.
〔試験3:単細胞化粉末中のビタミンCの安定性調査〕
(単細胞化粉末の作成)
青果パプリカ10gに、ペクチナーゼ(マセロチームA(登録商標):ヤクルト薬品工業社製)を作用させ、その他の条件は試験2−2と全く同一にしてパプリカ単細胞化粉末0.13gを得た(以下、実施例5とする)。比較対照には、パプリカを粉砕して凍結乾燥したパプリカ粉末(以下、比較例3とする)を使用した。また、比較対照として、L−アスコルビン酸(ナカライテスク製:純度99.5%、以下、比較例4とする)のデータも測定した。
[Test 3: Investigation of the stability of vitamin C in unicellularized powder]
(Making unicellular powder)
Pectinase (Maceroteam A (registered trademark): Yakult Yakuhin Kogyo Co., Ltd.) was allowed to act on 10 g of fruit and vegetable paprika, and 0.13 g of paprika unicellular powder was obtained under the same conditions as in Test 2-2 (hereinafter referred to as “paprika single cell powder”). Example 5). For comparison, paprika powder (hereinafter referred to as Comparative Example 3) obtained by pulverizing and freeze-drying paprika was used. As a comparative control, data of L-ascorbic acid (manufactured by Nacalai Tesque: purity 99.5%, hereinafter referred to as Comparative Example 4) was also measured.
(加速試験及びビタミンC定量)
パプリカにはビタミンC(アスコルビン酸)が多く含まれている。細胞膜が破損されずに良い状態を保持している程、ビタミンCは細胞膜によって保護され、安定化する。そこで、実施例5、比較例3、比較例4の各粉末に対し、湿度5%、温度45℃の条件下で3日間の加速試験を行い、前後のビタミンC量を、ビタミンC定量キット(コスモ・バイオ社製)を用いて定量し、各粉末0.01gあたりのビタミンC残存率(%:加速試験後の残存ビタミンC量/加速試験前のビタミンC量)を求めた。結果は、以下の表4に示すとおりとなった。
(Acceleration test and vitamin C determination)
Paprika is rich in vitamin C (ascorbic acid). Vitamin C is protected and stabilized by the cell membrane as the cell membrane remains in good condition without being damaged. Therefore, the powders of Example 5, Comparative Example 3 and Comparative Example 4 were subjected to an accelerated test for 3 days under the conditions of 5% humidity and 45 ° C. The amount of vitamin C remaining per 0.01 g of each powder (%: amount of residual vitamin C after accelerated test / vitamin C amount before accelerated test) was determined. The results were as shown in Table 4 below.
表4により明らかなように、本発明にかかる単細胞化粉末は、細胞膜が破損されずに良い状態を保持しているため、細胞内のビタミンCは、比較例3の凍結乾燥粉末や比較例4のL−アスコルビン酸と比較して格段に安定していることが確認された。 As is clear from Table 4, since the unicellularized powder according to the present invention maintains a good state without damaging the cell membrane, the intracellular vitamin C is lyophilized in Comparative Example 3 or Comparative Example 4. Compared with L-ascorbic acid, it was confirmed that it was much more stable.
〔試験4:βカロテンの溶出試験〕
試験3で作成した実施例5のパプリカ単細胞化粉末0.05gを用いて胃液処理又は腸液処理を行い、βカロテンの溶出試験を実施した。比較対照としては、極刻みにしたパプリカ青果0.5g(水分含量90%)を検体とした(以下、比較例5とする。)。
[Test 4: β-carotene dissolution test]
Gastric juice treatment or intestinal juice treatment was performed using 0.05 g of the paprika single cell powder of Example 5 prepared in Test 3, and a β-carotene elution test was conducted. As a comparative control, 0.5 g of paprika fruits and vegetables (water content 90%), which were extremely chopped, was used as a specimen (hereinafter referred to as Comparative Example 5).
胃液にはペプシン4%を含む日本薬局方崩壊試験の第1液50ml、腸液にはトリプシン2%及びパンクレアチン2%を含む第2液50mlを使用した。胃液処理は37℃にて2時間、腸液処理は37℃にて3時間それぞれをインキュベートした。 The gastric juice used was 50 ml of the first solution of the Japanese Pharmacopoeia containing 4% pepsin, and the intestinal fluid was 50 ml of the second solution containing 2% trypsin and 2% pancreatin. The gastric juice treatment was incubated at 37 ° C. for 2 hours, and the intestinal juice treatment was incubated at 37 ° C. for 3 hours.
その後、βカロテンの極大吸収波長(453nm)の吸光度を測定し、溶出したβカロテンの吸光度の値を比較した。結果は、以下の表5に示すとおりとなった。 Thereafter, the absorbance at the maximum absorption wavelength (453 nm) of β-carotene was measured, and the absorbance values of the eluted β-carotene were compared. The results were as shown in Table 5 below.
比較例5のパプリカでは総溶出量0.1736に対し、胃液処理0.1225となっており、総量の70%が胃液処理で溶出している。これに対して、本発明にかかるパプリカ単細胞化粉末では、総溶出量0.7570に対し、腸液処理0.5807となっており、76%が腸液処理で溶出している。この結果から、本発明のパプリカ単細胞化粉末を経口摂取した場合、その細胞内のβカロテンが主に腸で溶出するというドラッグデリバリーシステムの機能を持つことが明らかとなった。さらに、本発明のパプリカ単細胞化粉末は青果の4倍のβカロテンが溶出したことから、青果に比べ消化性も格段に高まることが確認された。 In the paprika of Comparative Example 5, the gastric juice treatment was 0.1225 with respect to the total elution amount of 0.1736, and 70% of the total amount was eluted by the gastric juice treatment. On the other hand, in the paprika single cell-ized powder according to the present invention, the total elution amount is 0.7570, the intestinal fluid treatment is 0.5807, and 76% is eluted by the intestinal fluid treatment. From this result, it was clarified that when the paprika single-cellized powder of the present invention is orally ingested, β-carotene in the cell has a function of a drug delivery system mainly eluting in the intestine. Furthermore, since the paprika single cell powder of the present invention eluted β-carotene four times as much as the fruits and vegetables, it was confirmed that the digestibility was remarkably increased as compared with the fruits and vegetables.
〔試験5:タンパク質の消化試験〕
試験2−2と全く同一の製法で得られた人参単細胞化粉末(以下、実施例6とする。)を使用して、胃及び腸でのタンパク質の消化試験を実施した。
[Test 5: Protein digestion test]
Using a ginseng unicellularized powder obtained in exactly the same manner as in Test 2-2 (hereinafter referred to as Example 6), a protein digestion test in the stomach and intestine was performed.
胃液及び腸液は試験4と同じ方法で調整した。実施例6の人参単細胞化粉末を胃液又は腸液に懸濁し、37℃にて1時間インキュベートし、胃液中及び腸液中の細胞内のタンパク質残量、及び処理液中に遊離するアミノ酸としてロイシンを定量し、それぞれ消化前のタンパク質に対する分解率、及びロイシン量の経時変化を調査した。結果は、図6のグラフに示すとおりとなった。 Gastric juice and intestinal fluid were prepared in the same manner as in Test 4. The ginseng unicellular powder of Example 6 is suspended in gastric juice or intestinal fluid, incubated at 37 ° C. for 1 hour, and the amount of protein remaining in the gastric juice and intestinal fluid is determined, and leucine is quantified as an amino acid released in the treatment fluid. Then, the degradation rate with respect to the protein before digestion and the change over time in the amount of leucine were investigated. The result was as shown in the graph of FIG.
図6のグラフに示すように、実施例6の人参単細胞化粉末は、胃液処理ではタンパク質の分解は進まず、タンパク質の分解により遊離するアミノ酸(ロイシン)量は15〜60分の間でほとんど変化しない。一方、腸液処理ではタンパク質の分解が進み、その分解に対応して遊離アミノ酸(ロイシン)量が増加している。1時間の胃液処理でのタンパク質分解率は総量の10%未満、腸液処理でのタンパク質分解率は総量の33%となった。この結果から、本発明の単細胞化粉末は、経口摂取した場合、胃内では細胞内タンパク質の安定性が保たれ、腸内では細胞膜が乱れて、たんぱく質が放出及び分解されるドラッグデリバリーシステムの機能を有することが確認された。 As shown in the graph of FIG. 6, the ginseng unicellularized powder of Example 6 did not progress in protein degradation during gastric juice treatment, and the amount of amino acid (leucine) released by protein degradation almost changed between 15 and 60 minutes. do not do. On the other hand, in the intestinal juice treatment, protein degradation proceeds, and the amount of free amino acid (leucine) increases corresponding to the degradation. The proteolysis rate in the gastric juice treatment for 1 hour was less than 10% of the total amount, and the proteolysis rate in the intestinal fluid treatment was 33% of the total amount. From this result, when the unicellularized powder of the present invention is orally ingested, the stability of intracellular protein is maintained in the stomach, the cell membrane is disturbed in the intestine, and the function of the drug delivery system in which the protein is released and degraded. It was confirmed to have
以上説明したように、本発明によれば、シクロデキストリンが単細胞化された植物の細胞の周囲に集まってミセルを形成して表面が親水基となり互いに電気的に反発するので、減圧蒸留濃縮もしくは遠心分離にて濃縮するときでも、単細胞同士の凝集及び密着、再結着が防止され、単細胞の状態を保ち細胞壁を破壊することなく粉末化することが可能となり、第1の課題を解決することができる。 As described above, according to the present invention, the cyclodextrin is collected around the cells of the unicellular plant to form micelles, the surfaces become hydrophilic groups and electrically repel each other. Even when concentrating by separation, aggregation, adhesion, and reattachment of single cells are prevented, and it becomes possible to maintain a single cell state and powder without destroying the cell wall, thereby solving the first problem. it can.
また、本発明の単細胞化粉末は、添加したシクロデキストリンが細胞膜の安定化剤として機能するので、懸濁液の凍結乾燥時や得られた単細胞化粉末の再懸濁する際にも、細胞膜の破損を防止でき、第2の課題も解決することができる。加えて、本発明によれば、以下の(1)(2)(3)の効果も得られる。 In addition, since the added cyclodextrin functions as a cell membrane stabilizer in the unicellularized powder of the present invention, the cell membrane can be used even when the suspension is lyophilized or when the obtained unicellularized powder is resuspended. Damage can be prevented and the second problem can be solved. In addition, according to the present invention, the following effects (1), (2), and (3) can also be obtained.
(1)噴霧乾燥が利用できること
本発明は、凍結乾燥だけでなく、噴霧乾燥も用いた場合でも、細胞内の状態を保って粉末化することができる。これは、噴霧乾燥の場合、例えば120℃以上の熱を加えることになるため、従来の粉末化方法では、細胞膜や細胞内成分に悪影響を与えることは避けられないという問題があったが、本発明では、シクロデキストリンが単細胞化された細胞の周囲に集合して膜を形成するため、このシクロデキストリンの膜によって細胞内への熱の伝達が可及的に遮断されるからである。
(1) Availability of spray drying The present invention can be powdered while maintaining the intracellular state even when spray drying is used as well as freeze drying. This is because, in the case of spray drying, for example, heat of 120 ° C. or higher is applied, and thus there has been a problem that the conventional powdering method inevitably adversely affects the cell membrane and intracellular components. This is because in the invention, cyclodextrin aggregates around a unicellular cell to form a membrane, so that the heat transfer into the cell is blocked as much as possible by this cyclodextrin membrane.
(2)粉末化された製品になった後に起きる細胞同士の接着も回避できること
単細胞化された植物の細胞壁表面に存在する水溶性多糖は吸湿性があるため、従来の粉末化方法では、粉末化された製品になった後においても、時間の経過とともに細胞壁表面が水分を含み、細胞同士が互いに接着してしまうという問題があった。しかし、本発明では、シクロデキストリン自体に吸湿性があるため、シクロデキストリンが細胞壁表面に存在する水溶性多糖に代わって水分を吸収するので、細胞壁表面が水分を含むことは可及的に抑制される。したがって、本発明では、粉末化された製品になった後に細胞同士が接着する問題点も解消され、製品の取り扱いが容易となる。
(2) It is possible to avoid cell-cell adhesion that occurs after becoming a powdered product. Since water-soluble polysaccharides present on the cell wall surface of unicellular plants are hygroscopic, conventional powdering methods use powders. Even after the product was made, there was a problem that the cell wall surface contained water and the cells adhered to each other over time. However, in the present invention, since the cyclodextrin itself is hygroscopic, the cyclodextrin absorbs water in place of the water-soluble polysaccharide present on the cell wall surface, so that the cell wall surface contains water as much as possible. The Therefore, in the present invention, the problem that cells adhere to each other after becoming a powdered product is solved, and the product can be handled easily.
(3)ドラッグデリバリーシステムとして利用できること
細胞膜は胃の環境下で分解されない。本発明により得られる単細胞化粉末は、細胞膜が破損することなく安定化しているので、植物が有する天然の機能性成分の変質及びロスを低減すると共に、経口摂取した場合に胃での分解を防止し、その後小腸に達した時はじめて細胞膜が乱れて細胞内成分を放出することができる。したがって、特に胃酸での変質によって著しく効果を失う機能性成分については、腸での吸収率が向上し、その有効利用率は格段に改善される。
(3) What can be used as a drug delivery system? A cell membrane is not decomposed in the stomach environment. Since the unicellularized powder obtained by the present invention is stabilized without damaging the cell membrane, it reduces deterioration and loss of natural functional components of the plant and prevents decomposition in the stomach when taken orally. Only after reaching the small intestine can the cell membrane be disturbed to release intracellular components. Therefore, especially about the functional component which loses an effect remarkably by alteration by gastric acid, the absorption rate in an intestine will improve and the effective utilization rate will be improved markedly.
本発明は上記実施例に限らず、各請求項に記載された技術的思想の範囲内で、適宜実施の形態を変更しても良い。 The present invention is not limited to the above embodiments, and the embodiments may be changed as appropriate within the scope of the technical idea described in each claim.
本発明の粉末化方法は、例えば、唐辛子、ゴーヤ、アロエ、にんにく、青パパイヤ、大豆、玉ねぎ、ウコン、長寿草など植物の種類は問わず、種々の植物を原材料とする健康食品や化粧品などに広く適用可能なものである。 The powdering method of the present invention is applicable to health foods and cosmetics made from various plants as raw materials, for example, regardless of plant types such as chili, bitter gourd, aloe, garlic, green papaya, soybeans, onions, turmeric, and longevity grass. Widely applicable.
Claims (9)
前記第1の工程により得られた単細胞化された植物を含む懸濁液にシクロデキストリンを添加する第2の工程と、
前記第2の工程により分散された細胞を含む懸濁液を減圧蒸留濃縮もしくは遠心分離にて濃縮する第3の工程と、
前記第3の工程により濃縮された懸濁液を凍結乾燥又は噴霧乾燥にて粉末化する第4の工程と、
を備えたことを特徴とする、単細胞化処理された植物の粉末化方法。 A first step of causing an intercellular substance-lytic enzyme to act on a plant;
A second step of adding cyclodextrin to the suspension containing the unicellularized plant obtained by the first step;
A third step of concentrating the suspension containing the cells dispersed in the second step by vacuum distillation concentration or centrifugation;
A fourth step of pulverizing the suspension concentrated in the third step by freeze drying or spray drying;
A method for pulverizing a plant that has been unicellularized, comprising:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008294779A JP5575386B2 (en) | 2007-11-19 | 2008-11-18 | Method for pulverizing plants that have been unicellularized |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007299571 | 2007-11-19 | ||
| JP2007299571 | 2007-11-19 | ||
| JP2008294779A JP5575386B2 (en) | 2007-11-19 | 2008-11-18 | Method for pulverizing plants that have been unicellularized |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009142267A true JP2009142267A (en) | 2009-07-02 |
| JP5575386B2 JP5575386B2 (en) | 2014-08-20 |
Family
ID=40913628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008294779A Expired - Fee Related JP5575386B2 (en) | 2007-11-19 | 2008-11-18 | Method for pulverizing plants that have been unicellularized |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5575386B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014185106A (en) * | 2013-03-22 | 2014-10-02 | Saraya Kk | Sophorolipid powder in which degradation of lactone type sophorolipid is inhibited |
| CN116200325A (en) * | 2023-02-28 | 2023-06-02 | 内蒙古金源康生物工程股份有限公司 | A kind of preparation method and product of water-soluble lipid complex |
Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03108469A (en) * | 1989-09-20 | 1991-05-08 | Yoshihide Hagiwara | Vegetable green juice powder and production thereof |
| JPH04271745A (en) * | 1991-02-27 | 1992-09-28 | Mercian Corp | Stabilized green vegetable powder and its preparation |
| JPH06105661A (en) * | 1992-05-14 | 1994-04-19 | Sawa Sangyo Kk | Production of vegetable unicellulated food |
| JPH08308534A (en) * | 1995-05-12 | 1996-11-26 | Yoshihide Hagiwara | Water-insoluble plant powder |
| JPH09234013A (en) * | 1996-02-28 | 1997-09-09 | Akita Pref Gov | Production of green totyuu tea powder |
| JPH1080251A (en) * | 1996-09-09 | 1998-03-31 | Morikawa Kenkoudou Kk | Improved edible flower powder and its production |
| JPH119218A (en) * | 1997-06-19 | 1999-01-19 | Yukiguni Maitake:Kk | Production of dried powder from broth of grifola frondosa s.f. gray |
| JPH1175791A (en) * | 1997-09-16 | 1999-03-23 | Yoshihide Hagiwara | Production of green leaf juice or green leaf juice powder of green plant |
| JP2001103918A (en) * | 1999-10-05 | 2001-04-17 | Maruzen Pharmaceut Co Ltd | Method for improving gustatoriness and gustatoriness- improved persimmon juice preparation |
| JP2001178427A (en) * | 2000-11-13 | 2001-07-03 | Kurorera Kogyo Kk | Dehydrated matter of plant and beverage, food color and feed for animal plankton using the same and method for producing dehydrated matter of plant |
| JP2002186444A (en) * | 2000-12-18 | 2002-07-02 | Madoonu:Kk | Granule of extracted solution of fruit and method for producing the same |
| JP2002187842A (en) * | 2000-12-19 | 2002-07-05 | Toyo Shinyaku:Kk | Kale processed product and its processing method |
| JP2003204771A (en) * | 2002-01-11 | 2003-07-22 | Miki Foods Co Ltd | Prune fiber food |
| JP2004008167A (en) * | 2002-06-11 | 2004-01-15 | Toyo Shinyaku:Kk | Method for producing fermented onion |
| JP2006094853A (en) * | 2004-09-01 | 2006-04-13 | Toyo Shinyaku:Kk | Fermented product obtained from garlic |
| JP2006217856A (en) * | 2005-02-10 | 2006-08-24 | Okuno Chem Ind Co Ltd | Powdered green tea composition |
| JP2009508472A (en) * | 2005-08-11 | 2009-03-05 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Methods and compositions for dry cell morphology |
-
2008
- 2008-11-18 JP JP2008294779A patent/JP5575386B2/en not_active Expired - Fee Related
Patent Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03108469A (en) * | 1989-09-20 | 1991-05-08 | Yoshihide Hagiwara | Vegetable green juice powder and production thereof |
| JPH04271745A (en) * | 1991-02-27 | 1992-09-28 | Mercian Corp | Stabilized green vegetable powder and its preparation |
| JPH06105661A (en) * | 1992-05-14 | 1994-04-19 | Sawa Sangyo Kk | Production of vegetable unicellulated food |
| JPH08308534A (en) * | 1995-05-12 | 1996-11-26 | Yoshihide Hagiwara | Water-insoluble plant powder |
| JPH09234013A (en) * | 1996-02-28 | 1997-09-09 | Akita Pref Gov | Production of green totyuu tea powder |
| JPH1080251A (en) * | 1996-09-09 | 1998-03-31 | Morikawa Kenkoudou Kk | Improved edible flower powder and its production |
| JPH119218A (en) * | 1997-06-19 | 1999-01-19 | Yukiguni Maitake:Kk | Production of dried powder from broth of grifola frondosa s.f. gray |
| JPH1175791A (en) * | 1997-09-16 | 1999-03-23 | Yoshihide Hagiwara | Production of green leaf juice or green leaf juice powder of green plant |
| JP2001103918A (en) * | 1999-10-05 | 2001-04-17 | Maruzen Pharmaceut Co Ltd | Method for improving gustatoriness and gustatoriness- improved persimmon juice preparation |
| JP2001178427A (en) * | 2000-11-13 | 2001-07-03 | Kurorera Kogyo Kk | Dehydrated matter of plant and beverage, food color and feed for animal plankton using the same and method for producing dehydrated matter of plant |
| JP2002186444A (en) * | 2000-12-18 | 2002-07-02 | Madoonu:Kk | Granule of extracted solution of fruit and method for producing the same |
| JP2002187842A (en) * | 2000-12-19 | 2002-07-05 | Toyo Shinyaku:Kk | Kale processed product and its processing method |
| JP2003204771A (en) * | 2002-01-11 | 2003-07-22 | Miki Foods Co Ltd | Prune fiber food |
| JP2004008167A (en) * | 2002-06-11 | 2004-01-15 | Toyo Shinyaku:Kk | Method for producing fermented onion |
| JP2006094853A (en) * | 2004-09-01 | 2006-04-13 | Toyo Shinyaku:Kk | Fermented product obtained from garlic |
| JP2006217856A (en) * | 2005-02-10 | 2006-08-24 | Okuno Chem Ind Co Ltd | Powdered green tea composition |
| JP2009508472A (en) * | 2005-08-11 | 2009-03-05 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Methods and compositions for dry cell morphology |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014185106A (en) * | 2013-03-22 | 2014-10-02 | Saraya Kk | Sophorolipid powder in which degradation of lactone type sophorolipid is inhibited |
| CN116200325A (en) * | 2023-02-28 | 2023-06-02 | 内蒙古金源康生物工程股份有限公司 | A kind of preparation method and product of water-soluble lipid complex |
Also Published As
| Publication number | Publication date |
|---|---|
| JP5575386B2 (en) | 2014-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Patel | Functional and engineered colloids from edible materials for emerging applications in designing the food of the future | |
| Al-Hamayda et al. | Advances in microencapsulation techniques using Arabic gum: A comprehensive review | |
| Waterhouse et al. | Spray-drying of antioxidant-rich blueberry waste extracts; interplay between waste pretreatments and spray-drying process | |
| Torres-Giner et al. | Nanoencapsulation of Aloe vera in synthetic and naturally occurring polymers by electrohydrodynamic processing of interest in food technology and bioactive packaging | |
| Laine et al. | Storage stability of microencapsulated cloudberry (Rubus chamaemorus) phenolics | |
| Albuquerque et al. | Approaches in biotechnological applications of natural polymers | |
| EP1641832B1 (en) | Method for preparing fibre-containing pectin and products and uses hereof | |
| KR101152167B1 (en) | Functional nano starch complexes and their preparation methods | |
| CN103951761B (en) | The method of enzymic degradation sea grass polysaccharide | |
| CN104001180B (en) | A kind of preparation method of marine alga natural antioxidant | |
| CN115089729B (en) | A preparation method of β-cyclodextrin purple sweet potato anthocyanin microcapsules | |
| Ćujić-Nikolić et al. | Application of gum Arabic in the production of spray-dried chokeberry polyphenols, microparticles characterisation and in vitro digestion method | |
| EP0397227A1 (en) | Method of preparation of an antimicrobial particulate, its product and applications | |
| Tomas et al. | Recent progress in promoting the bioavailability of polyphenols in plant-based foods | |
| JP5575386B2 (en) | Method for pulverizing plants that have been unicellularized | |
| Geethalaxmi et al. | Tamarind seed polysaccharides, proteins, and mucilage: extraction, modification of properties, and their application in food | |
| Worku et al. | Encapsulated essential oils in protein-polysaccharide biopolymers: Characteristics and applications in the biomedical and food industries | |
| CN108338356B (en) | A kind of mannose erythritol lipid liposome wrapped with chitosan and preparation method thereof | |
| Mallika et al. | Separation and purification of alliinase and alliin from garlic (Allium sativum) | |
| Ruiz et al. | New polymers for encapsulation of nutraceutical compounds | |
| EP3595643A1 (en) | Oil-free carotenoid composition | |
| CN113208111A (en) | Preparation method of betacyanin microcapsule with composite wall material | |
| Tang et al. | Advances in intestinal-targeted release of phenolic compounds | |
| Chranioti et al. | Encapsulation of food ingredients | |
| EP3187511B1 (en) | Method for producing water-soluble pea polysaccharide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111116 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121115 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130814 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130903 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140610 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140702 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5575386 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |